The Medicines Company to Present at Bank of America 2007 Health Care Conference
Posted on: Tuesday, 22 May 2007, 18:00 CDT
The Medicines Company (NASDAQ: MDCO) is scheduled to present at the Bank of America 2007 Health Care Conference on Wednesday, May 30th , at 5:40pm Eastern Time (2:40pm Pacific Time). A company overview and outlook will be provided in the presentation.
The session will be webcast with a link available at The Medicines Company's website: http://www.themedicinescompany.com.
MDCO-G
About The Medicines Company
The Medicines Company is committed to delivering innovative, cost-effective acute care products in the worldwide hospital marketplace. The Company markets Angiomax(R) (bivalirudin) in the U.S. and other countries for use in patients undergoing coronary angioplasty, a procedure to clear restricted blood flow in arteries around the heart. The Company also has two products in late-stage development, Cleviprex(TM) (clevidipine) and cangrelor. The Company's website is http://www.themedicinescompany.com.
Source: Business Wire
Related Articles
- Evidence-Based to Value-Based Medicine
- Difficult Conversations in Medicine
- Media Cover DOE Nuclear Medicine Cuts
- Asian Regional Cooperative Council for Nuclear Medicine: A Model of Regional Cooperation
- Hippocratic Oaths-Medicine and Its Discontents
- Nuclear Medicine in the Spotlight at RSNA
- Mainstream and Alternative Medicine: Converging Paths Require Common Standards
- Nuclear Medicine Facility Survey: SNM 2003 Survey Reporting on 2002 Cost and Utilization
- Emergency Medicine On Call
- Family Medicine Today
 |
 |
User Comments (0)
RSS Feeds